Article info
PDFNews
EU news
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU
- Correspondence to Stephanie Kohl, Policy & Advocacy, European Association of Hospital Pharmacists, Brussels, Belgium; Stephanie.Kohl{at}eahp.eu
Citation
EMA/HMA joint statement on the scientific rationale supporting interchangeability of biosimilar medicines in the EU
Publication history
- First published October 25, 2022.
Online issue publication
October 18, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© European Association of Hospital Pharmacists 2022. No commercial re-use. See rights and permissions. Published by BMJ.